Literature DB >> 30703169

HuVarBase: A human variant database with comprehensive information at gene and protein levels.

Kaliappan Ganesan1, A Kulandaisamy1, S Binny Priya1, M Michael Gromiha1,2.   

Abstract

Human variant databases could be better exploited if the variant data available in multiple resources is integrated in a single comprehensive resource along with sequence and structural features. Such integration would improve the analyses of variants for disease prediction, prevention or treatment. The HuVarBase (HUmanVARiantdataBASE) assimilates publicly available human variant data at protein level and gene level into a comprehensive resource. Protein level data such as amino acid sequence, secondary structure of the mutant residue, domain, function, subcellular location and post-translational modification are integrated with gene level data such as gene name, chromosome number & genome position, DNA mutation, mutation type origin and rs ID number. Disease class has been added for the disease causing variants. The database is publicly available at https://www.iitm.ac.in/bioinfo/huvarbase. A total of 774,863 variant records, integrated in the HuVarBase, can be searched with options to display, visualize and download the results.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30703169      PMCID: PMC6354970          DOI: 10.1371/journal.pone.0210475

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Human variant databases are being created frequently with specific scopes and contents. Their significance ranges from accurately predicting the disease [1] to achieving personalized medicine [2]. However, as the scopes of these databases differ, variant related data is inevitably spread across a number of databases such as 1000 Genomes [3], COSMIC [4], ClinVar [5], SwissVar [6], Humsavar (https://www.uniprot.org/docs/humsavar) etc. These databases have various limitations, including the fact that the data structures of these databases are not compatible with each other. As a result, obtaining comprehensive information on a variant of interest is still challenging for geneticists, biologists and clinicians [7]. Although integrating resources for the analysis of variant data obtained through Next Generation Sequencing (NGS) has been reported earlier [8], the integration is for tools and pipelines and not for the variant data. Further, currently available variant databases do not include protein level data namely sequence, structural or functional information about the protein which has the variant. Moreover, for disease causing variants, the disease class information is not available in the current databases. Recently, Kulandaisamy et al. [9] reported the MutHTP, wherein, gene level and protein level information related to disease causing and neutral variants have been compiled in a comprehensive manner. However, MutHTP is limited to variants reported in human membrane proteins only. We present here the HuVarBase (HUmanVARiant dataBASE), which is a comprehensive database for collating human variant data along with protein level data such as secondary structure of the residue in which the mutation has occurred, protein domain, subcellular localization, post-translational modification and function of the protein in which the variant is reported. In addition, if a variant leads to disease, then the disease class information also is included. The database has been implemented in a searchable server and made available online

Materials and methods

Datasets and curation

An outline of the datasets and curation steps are given in Fig 1. The current human variant datasets available in 1000 Genomes [3], ClinVar [4], COSMIC [5], SwissVar [6] and Humsavar (https://www.uniprot.org/docs/humsavar) were downloaded and merged based on their UniProt [10] identifiers. If the UniProt identifiers were not available in the dataset, then the same were obtained from UniProt database using the Gene Name or sequence identifiers. For the COSMIC [5] dataset, variants reported in two or more tumor samples were designated as cancer causing (driver mutations) [11] and included in our databases. Remaining COSMIC variant data were not included in our database. If a variant is reported in more than one database, then the variant data is merged and the respective databases are mentioned in the source column. Protein sequences corresponding to the UniProt identifiers were obtained from the UniProt server. For a given variant, the neighboring residue information(three residues each, before and after the mutated residue) was taken from either the UniProt canonical protein sequence, or the UniProt isoform protein sequence, whichever had the amino acid residue in which the variant was reported. Protein Data Bank—PDB [12] identifiers of proteins and the secondary structure information of the variant residue were obtained from the SIFTS [13] database. Chromosome number and & genome position corresponding to the variants were collected from the neXtProt [14] database.
Fig 1

Schematic diagram describing the data collection, features and applications of HuVarBase.

Subcellular localization, function and post-translational modifications of the proteins were obtained from the UniProt database. Protein domains in which the variant residues were present were obtained from the Pfam (https://pfam.xfam.org) database [15]. The disease classes were obtained from the KEGG [16] database based on the disease description. If the disease description does not match with that of the KEGG database, then other sources like Genetic and Rare Diseases Information Center (https://rarediseases.info.nih.gov/) [17] and Genetic Testing Registry (https://www.ncbi.nlm.nih.gov/gtr/) [18] were referred to obtain the name of the disease or synonyms of the disease. Then using that particular information, disease class was obtained from KEGG database. The present scope of the HuVarBase is to include small-scale variants of ‘missense’, ‘insertion’ and ‘deletion’ types along with the ‘non-sense’ type. Large-scale variations like large copy number variations will be added in future versions of HuVarBase.

Web server and site

HuVarBase is available online at https://www.iitm.ac.in/bioinfo/huvarbase/ and it is meant to be used for non-clinical academic purposes only. The server works on a Linux-Apache-MySQL-PHP (LAMP) architecture. Most fields in this database are searchable by either entering keywords or by choosing a keyword in the drop down menu. Users can also choose the required fields to be shown in the search results. Hyperlinks are given in the search results to, GeneCards [19] for information on the gene in which the given variant has occurred, dbSNP server [20] for rs ID numbers, UniProt server for information on the protein of the variant, Jmol (http://www.jmol.org) to view the 3D structure of the protein with the variant residue, the protein sequence with color-coded residues to differentiate neutral and disease causing variants and to the source databases. The search results can also be downloaded as a single file. The Frequently Asked Questions section contains answers to common questions raised by the users. A brief tutorial is also available on how to search and obtain variant data from HuVarBase.

Results

HuVarBase database includes 702,048 disease causing variants of which, 652,399 are ‘missense’, 10,174 are ‘nonsense’, 8,850 are ‘insertion’, and 30,625 are ‘deletion’ variants. There are 72,815 neutral variants (i.e. limited or no evidence on the pathogenic role of the mutation) of which 66,191 are ‘missense’, 2,885 are ‘nonsense’, 259 are ‘insertion’, and 3,480 are ‘deletion’ variants. In total, there are 774,863 variants reported from 18,318 proteins. The number of variants contributed from each of the data sources to the HuVarBase is depicted in Fig 2.
Fig 2

Venn diagram depicting the number of variants contributed from each of the data sources.

For a given variant record, the fields included are; i) Gene level data: name of the gene which has the variant, chromosomal coordinates, DNA mutation, type of the mutation, dbSNP [20] rs ID number if available and origin, ii) Protein level data: protein mutation, UniProt and PDB IDs of the corresponding protein, UniProt ID of the canonical or isoform of the protein in which the mutation has been reported, neighboring amino acids of the mutated amino acid, secondary structure of the particular amino acid residue, conservation score of the residue change, function of the protein, protein domain in which the mutation has occurred, subcellular localization of the protein and post-translational modifications of the protein, and iii) others: Disease or tissue type in which the variant has been reported, disease class and the source database. Statistics regarding the database such as disease class frequency matrices for the disease causing and neutral mutations, etc. are given in the web server. Table 1 gives a comparison of features included in currently available human variant databases with HuVarBase.
Table 1

Comparison of features in HuVarBase with existing databases.

FeaturesHumsavarSwissVar1000 GenomesCOSMICClinVarMutHTPHuVarBase
Gene nameYesYesYesPartialYesYesYes
Chromosome numberNoNoYesYesYesYesYes
Origin of mutationNoYesNoYesYesYesYes
DNA MutationNoNoNoYesYesYesYes
Type of mutationMissenseMissenseMissenseAllAllMissense, Insertion, DeletionMissense, Nonsense, Insertion, Deletion
rs ID numberYesYesYesNoYesNoYes
UniProt IDYesYesYesPartialPartialYesYes
3D structure (PDB)NoYesNoYesNoYesYes
Disease classNoNoNoYesNoYesYes
Conservation scoreNoNoNoNoNoYesYes
Neighbouring residuesNoNoNoNoNoYesYes
UniProt ID of IsoformsNoNoYesNoNoYesYes
Protein DomainNoNoNoNoNoYesYes
Protein FunctionNoNoNoNoNoNoYes
Subcellular LocationNoNoNoNoNoNoYes
PTM*NoNoNoNoNoNoYes
Secondary structureNoNoNoNoNoNoYes
OrganismHumanHumanHumanHumanHumanHuman (membrane proteins)Human

* PTM—Post Translational Modifications

* PTM—Post Translational Modifications

Applications

The comprehensive HuVarBase facilitates searching for a variant and obtaining variant-related sequence and structural information for viewing or downloading. The HuVarBase includes small scale variant types such as ‘missense’, ‘insertion’and ‘deletion’ along with the type ‘non-sense’ in the human genome. The applications of HuVarBase range from analysis, disease prediction to personalized medicine as exemplified by earlier efforts [21-23]. Analysis of the variants can be performed at sequence and structural level, in order to understand the effects of mutations leading to disease. Prediction algorithms requiring a comprehensive variant dataset can make use of the vast dataset available with the HuVarBase. The database will be updated periodically. The updates will be on a quarterly basisand the update information will be reflected in the ‘What’s New’ section of the web server.
  23 in total

1.  dbSNP: the NCBI database of genetic variation.

Authors:  S T Sherry; M H Ward; M Kholodov; J Baker; L Phan; E M Smigielski; K Sirotkin
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

2.  MutHTP: mutations in human transmembrane proteins.

Authors:  A Kulandaisamy; S Binny Priya; R Sakthivel; Svetlana Tarnovskaya; Ilya Bizin; Peter Hönigschmid; Dmitrij Frishman; M Michael Gromiha
Journal:  Bioinformatics       Date:  2018-07-01       Impact factor: 6.937

Review 3.  DNA variant databases improve test accuracy and phenotype prediction in Alport syndrome.

Authors:  Judy Savige; Elisabet Ars; Richard G H Cotton; David Crockett; Hayat Dagher; Constantinos Deltas; Jie Ding; Frances Flinter; Genevieve Pont-Kingdon; Nizar Smaoui; Roser Torra; Helen Storey
Journal:  Pediatr Nephrol       Date:  2013-05-30       Impact factor: 3.714

4.  MAPPIN: a method for annotating, predicting pathogenicity and mode of inheritance for nonsynonymous variants.

Authors:  Nehal Gosalia; Aris N Economides; Frederick E Dewey; Suganthi Balasubramanian
Journal:  Nucleic Acids Res       Date:  2017-10-13       Impact factor: 16.971

5.  A global reference for human genetic variation.

Authors:  Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

6.  Somatic cancer variant curation and harmonization through consensus minimum variant level data.

Authors:  Deborah I Ritter; Sameek Roychowdhury; Angshumoy Roy; Shruti Rao; Melissa J Landrum; Dmitriy Sonkin; Mamatha Shekar; Caleb F Davis; Reece K Hart; Christine Micheel; Meredith Weaver; Eliezer M Van Allen; Donald W Parsons; Howard L McLeod; Michael S Watson; Sharon E Plon; Shashikant Kulkarni; Subha Madhavan
Journal:  Genome Med       Date:  2016-11-04       Impact factor: 11.117

7.  Text Mining Genotype-Phenotype Relationships from Biomedical Literature for Database Curation and Precision Medicine.

Authors:  Ayush Singhal; Michael Simmons; Zhiyong Lu
Journal:  PLoS Comput Biol       Date:  2016-11-30       Impact factor: 4.475

8.  Easy retrieval of single amino-acid polymorphisms and phenotype information using SwissVar.

Authors:  Anaïs Mottaz; Fabrice P A David; Anne-Lise Veuthey; Yum L Yip
Journal:  Bioinformatics       Date:  2010-01-26       Impact factor: 6.937

9.  SIFTS: Structure Integration with Function, Taxonomy and Sequences resource.

Authors:  Sameer Velankar; José M Dana; Julius Jacobsen; Glen van Ginkel; Paul J Gane; Jie Luo; Thomas J Oldfield; Claire O'Donovan; Maria-Jesus Martin; Gerard J Kleywegt
Journal:  Nucleic Acids Res       Date:  2012-11-29       Impact factor: 16.971

10.  CRCDA--Comprehensive resources for cancer NGS data analysis.

Authors:  Manonanthini Thangam; Ramesh Kumar Gopal
Journal:  Database (Oxford)       Date:  2015-10-08       Impact factor: 3.451

View more
  10 in total

1.  XMAn v2-a database of Homo sapiens mutated peptides.

Authors:  Marcela Aguilera Flores; Iulia M Lazar
Journal:  Bioinformatics       Date:  2020-02-15       Impact factor: 6.937

2.  A transient reporter for editing enrichment (TREE) in human cells.

Authors:  Kylie Standage-Beier; Stefan J Tekel; Nicholas Brookhouser; Grace Schwarz; Toan Nguyen; Xiao Wang; David A Brafman
Journal:  Nucleic Acids Res       Date:  2019-11-04       Impact factor: 16.971

3.  VarSite: Disease variants and protein structure.

Authors:  Roman A Laskowski; James D Stephenson; Ian Sillitoe; Christine A Orengo; Janet M Thornton
Journal:  Protein Sci       Date:  2019-10-27       Impact factor: 6.725

4.  Identification of Tumor Antigens in the HLA Peptidome of Patient-derived Xenograft Tumors in Mouse.

Authors:  Nataly Mancette Rijensky; Netta R Blondheim Shraga; Eilon Barnea; Nir Peled; Eli Rosenbaum; Aron Popovtzer; Solomon M Stemmer; Alejandro Livoff; Mark Shlapobersky; Neta Moskovits; Dafna Perry; Eitan Rubin; Itzhak Haviv; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2020-05-25       Impact factor: 5.911

5.  The Participation of the Intrinsically Disordered Regions of the bHLH-PAS Transcription Factors in Disease Development.

Authors:  Marta Kolonko-Adamska; Vladimir N Uversky; Beata Greb-Markiewicz
Journal:  Int J Mol Sci       Date:  2021-03-11       Impact factor: 5.923

Review 6.  Genome interpretation using in silico predictors of variant impact.

Authors:  Panagiotis Katsonis; Kevin Wilhelm; Amanda Williams; Olivier Lichtarge
Journal:  Hum Genet       Date:  2022-04-30       Impact factor: 5.881

7.  Novel clinical, molecular and bioinformatics insights into the genetic background of autism.

Authors:  Ioanna Talli; Nikolas Dovrolis; Anastasis Oulas; Stavroula Stavrakaki; Kali Makedou; George M Spyrou; Ioanna Maroulakou
Journal:  Hum Genomics       Date:  2022-09-18       Impact factor: 6.481

8.  Prediction of infectivity of SARS-CoV-2 virus based on Spike-hACE-2 interaction.

Authors:  Dwaipayan Chaudhuri; Joyeeta Datta; Satyabrata Majumder; Kalyan Giri
Journal:  Virusdisease       Date:  2022-08-05

Review 9.  Computational approaches for predicting variant impact: An overview from resources, principles to applications.

Authors:  Ye Liu; William S B Yeung; Philip C N Chiu; Dandan Cao
Journal:  Front Genet       Date:  2022-09-29       Impact factor: 4.772

10.  Correction of a Factor VIII genomic inversion with designer-recombinases.

Authors:  Felix Lansing; Liliya Mukhametzyanova; Teresa Rojo-Romanos; Kentaro Iwasawa; Masaki Kimura; Maciej Paszkowski-Rogacz; Janet Karpinski; Tobias Grass; Jan Sonntag; Paul Martin Schneider; Ceren Günes; Jenna Hoersten; Lukas Theo Schmitt; Natalia Rodriguez-Muela; Ralf Knöfler; Takanori Takebe; Frank Buchholz
Journal:  Nat Commun       Date:  2022-01-20       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.